Skip Ribbon Commands
Skip to main content

DMO research staff comprises clinician scientist/investigators and basic scientists. They are collaborating seamlessly to explore the knowledge of cancer mechanism and develop novel cancer treatments to improve patient’s life. 

Clinician Scientists

Singapore Translational Research Investigator Award holders:

  • Prof Toh Han Chong – PI of study ‘The VICTORY (Virus-Induced Cancer: Translational Oncology Research & Immunology) Consortium’, 2018 - 2023
  • Prof Lim Soon Thye – PI of study ‘The Singapore lYMPHoma translatiONal studY (SYMPHONY)’, 2019 -2024
  • Dr Daniel Tan Shao Weng – PI of study ‘Next-Generation Clinical Trials and Integrative Research for Fighting Lung Cancer’,  2019 - 2024

Clinician Scientist Award holders:   

  • Dr Iain Tan – PI Senior Investigator of study ‘Characterizing the immune microenvironment to inform stratified immunotherapeutic approaches in MSS metastatic Colorectal cancer (MSS-mCRC), 2023 - 2028
  • Dr Toh Han Chong – Senior Investigator of study ‘Novel therapeutic interventions to target GATA4-related pathways in hepatocellular carcinoma’, 2017 – 2022
  • Dr Yap Yoon Sim – PI of study ‘Tracking circulating tumour cells and microRNAs in high-risk breast cancer’, 2019 – 2022
  • Dr Darren Lim – PI of study ‘Elucidating the immunobiology of nasopharyngeal carcinoma’, 2020 – 2023
  • Dr Daniel Tan – PI of study ‘Deciphering the tumor microenvironment of primary TKI resistant EGFR mutant NSCLC’, 2020 – 2023
  • Dr Joanne Ngeow – PI of study ‘Understanding Tumour Predisposition in Asia (UToPIA) Study: From Patient-Centered Research to the Clinic’ 2021 – 2024

Transition Award holders:

  • Dr Dawn Chong – Diet-Derived Metabolites and the Risk of Colorectal Cancer: A Nested Case-Control Study in a Population-Based Cohort, the Singapore Chinese Health Study, 2018 – 2023
  • Dr Valerie Yang Shiwen - The Immune Microenvironment in Soft Tissue Sarcomas and Therapeutic Implications for Immunotherapy, 2021 - 2024 
  • Dr Jason Chan Yongsheng – Understanding Therapeutic Resistance in Gastrointestinal Stromal Tumors Beyond Genomics, 2022 - 2025


Clinician Investigators

Breast / Gynae Oncology ​
​Head of Department​Dr Mabel WONG
Senior Consultant​

​Dr Rebecca DENT

Dr Yoon Sim YAP

Dr Elaine Hsuen LIM

Dr Raymond NG

Dr Tira TAN

Dr Lay Tin SOH

Dr Wen Yee CHAY


Associate Consultant

Dr Junjie Jack CHAN

Dr Ying Cong Ryan Shea TAN

Dr Wai Yee Rose FOK

Dr Sok Yuen BEH

Dr Wu Meng TAN

Dr Zewen ZHANG

Dr Bernard CHUA

Dr Jun MA

Lymphoma / Sarcoma Oncology ​
​Head of DepartmentDr Nagavalli D/O Somasundaram
​​Senior Consultant​

Prof Soon Thye LIM

Dr Miriam TAO

Dr Mohamad Farid Bin Harunal Rashid


​Dr Eileen Yi Ling POON

Dr Jason Yong Sheng CHAN

Dr Esther Wei Yin CHANG

Dr Valerie Shiwen YANG

Dr Jianbang CHIANG

​Associate Consultant

​Dr Ya Hwee TAN

Dr Tian Ming Joshua HOE

​​Gastrointestinal / Neuro / Hepatobiliary Oncology
​Head of DepartmentDr Matthew NG
​Senior Consultant​

​Prof Han Chong TOH

Dr Chee Kian THAM

Dr Joanne NGEOW 

A/Prof Iain TAN

Dr David TAI

Dr Clarinda CHUA


Dr Si-Lin KOO

A/Prof Wen Hsin KOO

A/Prof Simon ONG

Dr Sin Jen ONG


Dr Justina Yick Ching LAM

Dr Joycelyn Jie Xin LEE

Dr Chiew Woon LIM

Dr Shuting HAN

​Associate Consultant

Dr Suat Ying LEE

Dr Yao Yi Kennedy NG

Dr Yi Ting Evelyn WONG

Thoracic /Head & Neck / Urologic Oncology​ ​
​Head of Department ​Dr Mei Kim ANG
Senior Consultant​

A/Prof Eng Huat TAN

A/Prof Darren LIM

Dr Quan Sing NG

A/Prof Daniel TAN

A/Prof Ravindran KANESVARAN

Dr Amit Jain


Dr Wan Ling TAN

Dr Gillianne Geet Yi LAI

Dr Yi Lin TEH

Dr Stephanie Pei Li SAW

Dr Johan Wai Kay CHAN

​Associate Consultant

​Dr Wei Chong TAN

Dr Aaron Chia-Ken TAN